Butterfly Network to Present Handheld Ultrasound Innovations at J.P. Morgan Healthcare Conference
- Butterfly Network will present advancements in handheld ultrasound technology at the J.P. Morgan Healthcare Conference on January 16, 2025.
- The company aims to democratize ultrasound access for 4.7 billion individuals worldwide with its innovative devices.
- Butterfly's Ultrasound-on-Chip™ technology enhances accessibility and affordability, supporting remote health management and early detection of medical conditions.
Butterfly Network to Showcase Innovations at J.P. Morgan Healthcare Conference
Butterfly Network, Inc. is set to participate in the upcoming 43rd Annual J.P. Morgan Healthcare Conference from January 13-16, 2025, in San Francisco. The conference serves as a pivotal platform for healthcare companies to present their innovations. On January 16 at 7:30 AM PST, Joseph DeVivo, President and CEO, alongside Heather Getz, EVP and CFO, will deliver a presentation highlighting the company's advancements in handheld ultrasound technology. Following the presentation, a replay will be accessible on Butterfly's investor website until February 15, 2025, allowing broader access to their strategic insights.
Founded in 2011 by Dr. Jonathan Rothberg, Butterfly Network is committed to democratizing ultrasound access for the estimated 4.7 billion individuals worldwide lacking this essential imaging tool. The company has made significant strides in the medical imaging field with its pioneering handheld whole-body ultrasound system. The flagship product, Butterfly iQ, launched several years ago, has evolved into more advanced iterations, including the second-generation Butterfly iQ+ in 2020 and the newly released iQ3 in 2024. Each generation boasts improved processing capabilities and performance metrics, reinforcing Butterfly’s position as a leader in portable ultrasound technology.
Butterfly Network's proprietary Ultrasound-on-Chip™ technology and innovative software solutions are central to its mission of enhancing accessibility and affordability in ultrasound imaging. This commitment is reflected in the widespread distribution of its devices to trained healthcare practitioners in diverse regions, including Africa, Asia, Europe, and the Americas. The company’s advancements have garnered significant recognition, including accolades such as TIME’s Best Inventions and a spot on the CNBC Disruptor 50 list, underscoring its transformative impact on healthcare delivery.
In addition to its technological innovations, Butterfly Network emphasizes the importance of remote health management. The company's devices facilitate early detection of medical conditions and allow healthcare practitioners to manage patient care from a distance, which is particularly beneficial in underserved areas. As Butterfly prepares to present its latest developments at the J.P. Morgan Healthcare Conference, it aims to reinforce its commitment to improving global health outcomes through accessible medical imaging solutions. For those interested in the availability of Butterfly’s products in specific regions, detailed information is available on their website.